Ixabepilone
Generic name: Ixabepilone
Brand names: Ixempra
Dosage form: intravenous powder for injection (15 mg; 45 mg)
Drug class:
Mitotic inhibitors
Usage of Ixabepilone
Ixabepilone is used to treat advanced breast cancer.
Ixabepilone is usually given after other treatments have failed.
Ixabepilone may also be used for purposes not listed in this medication guide.
Ixabepilone side effects
Get emergency medical help if you have signs of an allergic reaction: itching, hives, rash; feeling dizzy or faint; warmth or tingly feeling; difficulty breathing, chest tightness; pounding heartbeats or fluttering in your chest; swelling of your face, lips, tongue, or throat.
Ixabepilone may cause serious side effects. Call your doctor at once if you have:
Common side effects of ixabepilone may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Ixabepilone
You should not be treated with ixabepilone if you are allergic to Cremophor (synthetic castor oil).
You may not be able to receive ixabepilone if you have:
Tell your doctor if you have ever had:
Ixabepilone may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.
You should not breastfeed while using ixabepilone.
Relate drugs
- Abraxane
- Cabazitaxel
- Docefrez
- Docetaxel
- Eribulin
- Etopophos
- Etoposide
- Etoposide (Intravenous)
- Etoposide (Oral)
- Etoposide injection
- Etoposide phosphate
- Halaven
- Ixabepilone
- Ixempra
- Jevtana
- Marqibo
- Navelbine
- Nov-Onxol
- Oncovin
- Onxol
- Paclitaxel
- Paclitaxel Novaplus
- Paclitaxel protein-bound
- Taxol
- Taxotere
- Teniposide
- Toposar injection
- Velban
- Vepesid (Etoposide Intravenous)
- Vepesid (Etoposide Oral)
- Vinblastine
- Vincasar PFS
- Vincristine
- Vincristine liposome
- Vinorelbine
- Vumon
How to use Ixabepilone
Usual Adult Dose for Breast Cancer:
Recommended dosage: 40 mg/m2 IV over 3 hours every 3 weeksThe dosage for patients with a body surface area (BSA) exceeding 2.2 m2 should be calculated based on a 2.2 m2 BSA.Comments:- All patients should be premedicated approximately 1 hour before the infusion (see Administration Advice).Uses: -In combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicated. ---Anthracycline resistance is defined as progression while on therapy or within 6 months in the adjuvant setting or 3 months in the metastatic setting. ---Taxane resistance is defined as progression while on therapy or within 12 months in the adjuvant setting or 4 months in the metastatic setting. -As monotherapy for the treatment of metastatic or locally advanced breast cancer in patients whose tumors are resistant or refractory to anthracyclines, taxanes, and capecitabine.
Warnings
You should not use ixabepilone along with capecitabine if you have liver problems.
Ixabepilone can increase your risk of bleeding or infection. Call your doctor if you have unusual bruising or bleeding, or new signs of infection (fever, chills, easy bruising, unusual bleeding, burning when you urinate).
What other drugs will affect Ixabepilone
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Many drugs can affect ixabepilone. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions